Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $1.6M $8.4M $44.7M $81.7M $66.8M $53.8M $94.3M $53.6M
Accounts Receivable $630.0K $700.0K $12.6M $18.7M $11.0M $6.0M $995.0K $1.0M
Inventory — — — — — — — —
Total Current Assets $3.8M $72.4M $70.8M $101.1M $80.0M $61.2M $97.9M $110.0M
Property, Plant & Equipment $730.0K $300.0K $200.0K $2.0M $4.3M $4.9M $84.0K $597.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $40.0K — — — $600.0K $1.8M — —
Total Assets $4.5M $72.7M $79.4M $114.0M $85.8M $69.3M $98.0M $113.9M
Liabilities
Accounts Payable $1.4M $3.9M $1.9M $2.8M $2.4M $2.9M $146.0K $552.0K
Total Current Liabilities $4.5M $9.2M $9.0M $26.9M $17.6M $9.5M $6.3M $17.9M
Long-Term Debt $15.9M — — — — — — —
Total Liabilities $43.2M $26.5M $9.9M $27.1M $17.8M $10.0M $39.1M $53.3M
Stockholders' Equity
Retained Earnings $-80.0M $-134.3M $-108.9M $-89.8M $-78.8M $-69.9M $-228.1M $-223.5M
Total Stockholders' Equity $-38.7M $-29.6M $69.5M $86.9M $68.0M $59.3M $58.9M $60.6M
← Newer Page 2 of 2 Older →